AB 1366: Reimbursement for pharmacist services.
- Session Year: 2025-2026
- House: Assembly
- Latest Version Date: 2026-01-05
Current Status:
Failed
(2026-02-02: From committee: Filed with the Chief Clerk pursuant to Joint Rule 56.)
Introduced
In Committee
Awaiting First Chamber Vote
Passed First Chamber
In Committee
Awaiting Second Chamber Vote
Passed Second Chamber
Enacted
Existing law provides for the Medi-Cal program, administered by the State Department of Health Care Services and under which health care services are provided to low-income individuals pursuant to a schedule of benefits. The Medi-Cal program is, in part, governed and funded by federal Medicaid program provisions. Under existing law, pharmacist services are a benefit under the Medi-Cal program, subject to federal approval, and the rate of reimbursement for pharmacist services is 85% of the fee schedule for physician services, except for medication therapy management (MTM) pharmacist services. Existing law requires the department to implement an MTM reimbursement methodology relating to the dispensing of qualified specialty drugs by an eligible contracting pharmacy, which would be intended to supplement Medi-Cal payments to eligible pharmacies for MTM pharmacist services provided in conjunction with certain specialty drug therapy categories.
This bill would instead additionally require the rate of reimbursement for advanced practice pharmacist services to be the same as the fee schedule for physician services, including MTM pharmacist services. The bill would require the department to implement an MTM reimbursement methodology relating to the use of drugs to ensure that Medi-Cal payments are only made to eligible advanced practice pharmacists or pharmacies for MTM pharmacist services provided in conjunction with certain specialty drug therapy categories.
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care, and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law requires a health care service plan or disability insurer that offers coverage for pharmacist services to pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy or a pharmacist at an out-of-network pharmacy if the insurer has an out-of-network pharmacy benefit. Existing law authorizes this payment or reimbursement when specified conditions are met, including that the coverage otherwise provides reimbursement for identical services performed by other licensed health care providers.
This bill would additionally require those health care service plans and disability insurers to pay or reimburse the cost of the service performed by a an advanced practice pharmacist enrolled as a provider with the plan or insurer. The bill would authorize payment or reimbursement if the coverage otherwise provides reimbursement for similar services performed by other licensed health care providers, among other requirements. Because a willful violation of the bills requirements relative to health care service plans would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing law provides for the Medi-Cal program, administered by the State Department of Health Care Services and under which health care services are provided to low-income individuals pursuant to a schedule of benefits. The Medi-Cal program is, in part, governed and funded by federal Medicaid program provisions. Under existing law, pharmacist services are a benefit under the Medi-Cal program, subject to federal approval, and the rate of reimbursement for pharmacist services is 85% of the fee schedule for physician services, except for medication therapy management (MTM) pharmacist services. Existing law requires the department to implement an MTM reimbursement methodology relating to the dispensing of qualified specialty drugs by an eligible contracting pharmacy, which would be intended to supplement Medi-Cal payments to eligible pharmacies for MTM pharmacist services provided in conjunction with certain specialty drug therapy categories.
This bill would instead require the rate of reimbursement for pharmacist services to be the same as the fee schedule for physician services, including MTM pharmacist services. The bill would require the department to implement an MTM reimbursement methodology relating to the use of drugs to ensure that Medi-Cal payments are only made to eligible pharmacists or pharmacies for MTM pharmacist services provided in conjunction with certain specialty drug therapy categories.
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care, and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law requires a health care service plan or disability insurer that offers coverage for pharmacist services to pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy or a pharmacist at an out-of-network pharmacy if the insurer has an out-of-network pharmacy benefit. Existing law authorizes this payment or reimbursement when specified conditions are met, including that the coverage otherwise provides reimbursement for identical services performed by other licensed health care providers.
This bill would additionally require those health care service plans and disability insurers to pay or reimburse the cost of the service performed by a pharmacist enrolled as a provider with the plan or insurer. The bill would authorize payment or reimbursement if the coverage otherwise provides reimbursement for similar services performed by other licensed health care providers, among other requirements. Because a willful violation of the bills requirements relative to health care service plans would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing law, the Pharmacy Law, establishes the California State Board of Pharmacy to administer its provisions and authorizes a pharmacist to, among other things, perform certain procedures or functions as specified.This bill would state the intent of the Legislature to enact subsequent legislation that establishes or clarifies the standard of care applicable to pharmacists in California.Existing law, the Pharmacy Law, establishes the California State Board of Pharmacy to administer its provisions and authorizes a pharmacist to, among other things, perform certain procedures or functions as specified.
This bill would state the intent of the Legislature to enact subsequent legislation that establishes or clarifies the standard of care applicable to pharmacists in California.
(a) A health care service plan that offers coverage for a service that is within the scope of practice of a duly licensed pharmacist shall pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy, a pharmacist at an out-of-network pharmacy if the health care service plan has an out-of-network pharmacy benefit, or a an advanced practice pharmacist enrolled as a provider with the health care service plan.
(b) Payment or reimbursement may be made pursuant to this section for a service performed by a duly licensed pharmacist only when all of the following conditions are met:
(1) The service performed is within the lawful scope of practice of the pharmacist.
(2) The coverage otherwise provides reimbursement for similar services performed by other licensed health care providers.
(c) This section does not require the plan to pay a claim to more than one provider for duplicate service or be interpreted to limit physician reimbursement.
SEC. 2.Section 10125.1 of the Insurance Code is amended to read:10125.1.(a)An insurer issuing disability insurance that covers hospital, medical, or surgical expenses that offers coverage for a service that is within the scope of practice of a duly licensed pharmacist shall pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy, a pharmacist at an out-of-network pharmacy if the insurer has an out-of-network pharmacy benefit, or a an advanced practice pharmacist enrolled as a provider with the insurer.
(b)Payment or reimbursement may be made pursuant to this section for a service performed by a duly licensed pharmacist only when all of the following conditions are met:
(1)The service performed is within the lawful scope of practice of the pharmacist.
(2)The coverage otherwise provides reimbursement for similar services performed by other licensed health care providers.
(c)This section does not require the insurer to pay a claim to more than one provider for duplicate service or be interpreted to limit physician reimbursement.
SEC. 3.Section 14132.968 of the Welfare and Institutions Code is amended to read:14132.968.(a)(1)Pharmacist services are a benefit under the Medi-Cal program, subject to approval by the federal Centers for Medicare and Medicaid Services.
(2)The department shall establish a fee schedule for the list of pharmacist services.
(3)The rate of reimbursement for pharmacist services shall be at 85 percent of the fee schedule for physician services under the Medi-Cal program, except for medication therapy management (MTM) pharmacist services as described in Section 14132.969.
(3)(4)The rate of reimbursement for advanced practice pharmacist services shall be the same as the fee schedule for physician services under the Medi-Cal program, including medication therapy management (MTM) MTM pharmacist services as described in Section 14132.969.
(b)(1)The following services are covered pharmacist services that may be provided to a Medi-Cal beneficiary:
(A)Furnishing travel medications, as authorized in clause (3) of subparagraph (A) of paragraph (10) of subdivision (a) of Section 4052 of the Business and Professions Code.
(B)Furnishing naloxone hydrochloride, as authorized in Section 4052.01 of the Business and Professions Code.
(C)Furnishing self-administered hormonal contraception, as authorized in subdivision (a) of Section 4052.3 of the Business and Professions Code.
(D)Initiating and administering immunizations, as authorized in Section 4052.8 of the Business and Professions Code.
(E)Providing tobacco cessation counseling and furnishing nicotine replacement therapy, as authorized in Section 4052.9 of the Business and Professions Code.
(F)Initiating and furnishing preexposure prophylaxis, as authorized in Section 4052.02 of the Business and Professions Code.
(G)Initiating and furnishing postexposure prophylaxis, as authorized in Section 4052.03 of the Business and Professions Code.
(H)Providing MTM pharmacist services in conjunction with the use of qualified specialty drugs, as described in Section 14132.969.
(2)Covered pharmacist services shall be subject to department protocols and utilization controls.
(c)A pharmacist shall be enrolled as an ordering, referring, and prescribing provider under the Medi-Cal program before rendering a pharmacist service that is submitted by a pharmacist or a Medi-Cal pharmacy provider for reimbursement pursuant to this section.
(d)(1)The director shall seek any necessary federal approvals to implement this section. This section shall not be implemented until the necessary federal approvals are obtained and shall be implemented only to the extent that federal financial participation is available.
(2)This section does not restrict or prohibit services currently provided by pharmacists as authorized by law, including this chapter and the Medicaid state plan.
(e)The department shall seek federal approval of a state plan amendment to recognize pharmacists as health care providers at federally qualified health centers for reimbursement purposes under the Medi-Cal program.
(e)(f)Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section, and any applicable federal waivers and state plan amendments, by means of all-county letters, plan letters, plan or provider bulletins, or similar instructions, without taking regulatory action. By July 1, 2021, the department shall adopt regulations in accordance with the requirements of Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code. Commencing July 1, 2017, the department shall provide a status report to the Legislature on a semiannual basis, in compliance with Section 9795 of the Government Code, until regulations have been adopted.
SEC. 4.Section 14132.969 of the Welfare and Institutions Code is amended to read:14132.969.(a)Subject to an annual appropriation for this express purpose, the department shall implement a medication therapy management (MTM) reimbursement methodology for covered pharmacist services related to the use of qualified specialty drugs. MTM reimbursement pursuant to this section is intended to ensure Medi-Cal payments are only made to eligible advanced practice pharmacists or pharmacies for MTM pharmacist services provided in conjunction with certain specialty drug therapy categories, as identified by the department pursuant to paragraph (2) of subdivision (b).
(b)In implementing this section, the department shall do all of the following:
(1)Establish and maintain protocols and utilization controls for covered MTM pharmacist services.
(2)Establish and maintain a list of covered specialty drug therapy categories for which MTM pharmacist services reimbursement is available.
(3)Establish and maintain rates of reimbursement for covered MTM pharmacist services under contracts with participating pharmacies pursuant to subdivision (c).
(4)Establish and maintain the eligibility criteria and conditions for receipt of MTM pharmacist services reimbursement pursuant to this section.
(c)(1)MTM pharmacist services reimbursement pursuant to this section shall only be available to a Medi-Cal enrolled pharmacy or an eligible advanced practice pharmacist that enters into an MTM pharmacist services contract with the department.
(2)For purposes of implementing this section, the department may enter into exclusive or nonexclusive contracts, or amend existing contracts, on a bid or negotiated basis. Contracts entered into or amended pursuant to this subdivision shall be exempt from Chapter 6 (commencing with Section 14825) of Part 5.5 of Division 3 of Title 2 of the Government Code, Part 2 (commencing with Section 10100) of Division 2 of the Public Contract Code, and the State Administrative Manual, and shall be exempt from the review or approval of any division of the Department of General Services.
(d)(1)This section shall apply to dates of service on or after July 1, 2021, or to dates of service on or after the effective date reflected in any necessary federal approvals obtained by the department pursuant to paragraph (2), whichever is later.
(2)The department shall seek any necessary federal approvals to implement this section.
(3)This section shall be implemented only to the extent that any necessary federal approvals are obtained and federal financial participation is available and is not otherwise jeopardized.
(e)This section does not restrict or prohibit services currently provided by pharmacists as authorized by law, including this chapter and the Medicaid state plan.
(f)Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section, in whole or in part, by means of provider bulletins or other similar instructions, without taking any further regulatory action.
(g)For purposes of this section, the following definitions apply:
(1)Medication therapy management or MTM means a distinct service or group of services, as determined by the department, that are provided by pharmacists to improve health outcomes of beneficiaries who are at risk of treatment failure due to noncompliance, nonadherence, or other factors found to negatively affect drug therapy outcomes.
(2)Specialty drugs has the same meaning as set forth in paragraph (13) of subdivision (a) of Section 14105.45.
SEC. 5.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a) Every A health care service plan that offers coverage for a service that is within the scope of practice of a duly licensed pharmacist shall pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy or pharmacy, a pharmacist at an out-of-network pharmacy if the health care service plan has an out-of-network pharmacy benefit. benefit, or a pharmacist enrolled as a provider with the health care service plan.
(b) Payment or reimbursement may be made pursuant to this section for a service performed by a duly licensed pharmacist only when all of the following conditions are met:
(1) The service performed is within the lawful scope of practice of the pharmacist.
(2) The coverage otherwise provides reimbursement for identical similar services performed by other licensed health care providers.
(c) Nothing in this section shall This section does not require the plan to pay a claim to more than one provider for duplicate service or be interpreted to limit physician reimbursement.
SEC. 2.Section 10125.1 of the Insurance Code is amended to read:10125.1.(a)Every An insurer issuing disability insurance that covers hospital, medical, or surgical expenses that offers coverage for a service that is within the scope of practice of a duly licensed pharmacist shall pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy or pharmacy, a pharmacist at an out-of-network pharmacy if the insurer has an out-of-network pharmacy benefit. benefit, or a pharmacist enrolled as a provider with the insurer.
(b)Payment or reimbursement may be made pursuant to this section for a service performed by a duly licensed pharmacist only when all of the following conditions are met:
(1)The service performed is within the lawful scope of practice of the pharmacist.
(2)The coverage otherwise provides reimbursement for identical similar services performed by other licensed health care providers.
(c)Nothing in this section shall This section does not require the insurer to pay a claim to more than one provider for duplicate service or be interpreted to limit physician reimbursement.
SEC. 3.Section 14132.968 of the Welfare and Institutions Code is amended to read:14132.968.(a)(1)Pharmacist services are a benefit under the Medi-Cal program, subject to approval by the federal Centers for Medicare and Medicaid Services.
(2)The department shall establish a fee schedule for the list of pharmacist services.
(3)The rate of reimbursement for pharmacist services shall be at 85 percent of the same as the fee schedule for physician services under the Medi-Cal program, except for including medication therapy management (MTM) pharmacist services as described in Section 14132.969.
(b)(1)The following services are covered pharmacist services that may be provided to a Medi-Cal beneficiary:
(A)Furnishing travel medications, as authorized in clause (3) of subparagraph (A) of paragraph (10) of subdivision (a) of Section 4052 of the Business and Professions Code.
(B)Furnishing naloxone hydrochloride, as authorized in Section 4052.01 of the Business and Professions Code.
(C)Furnishing self-administered hormonal contraception, as authorized in subdivision (a) of Section 4052.3 of the Business and Professions Code.
(D)Initiating and administering immunizations, as authorized in Section 4052.8 of the Business and Professions Code.
(E)Providing tobacco cessation counseling and furnishing nicotine replacement therapy, as authorized in Section 4052.9 of the Business and Professions Code.
(F)Initiating and furnishing preexposure prophylaxis, as authorized in Section 4052.02 of the Business and Professions Code.
(G)Initiating and furnishing postexposure prophylaxis, as authorized in Section 4052.03 of the Business and Professions Code.
(H)Providing MTM pharmacist services in conjunction with the dispensing of use of qualified specialty drugs, as described in Section 14132.969.
(2)Covered pharmacist services shall be subject to department protocols and utilization controls.
(c)A pharmacist shall be enrolled as an ordering, referring, and prescribing provider under the Medi-Cal program prior to before rendering a pharmacist service that is submitted by a pharmacist or a Medi-Cal pharmacy provider for reimbursement pursuant to this section.
(d)(1)The director shall seek any necessary federal approvals to implement this section. This section shall not be implemented until the necessary federal approvals are obtained and shall be implemented only to the extent that federal financial participation is available.
(2)This section neither restricts nor prohibits any does not restrict or prohibit services currently provided by pharmacists as authorized by law, including, but not limited to, this chapter, or including this chapter and the Medicaid state plan.
(e)Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section, and any applicable federal waivers and state plan amendments, by means of all-county letters, plan letters, plan or provider bulletins, or similar instructions, without taking regulatory action. By July 1, 2021, the department shall adopt regulations in accordance with the requirements of Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code. Commencing July 1, 2017, the department shall provide a status report to the Legislature on a semiannual basis, in compliance with Section 9795 of the Government Code, until regulations have been adopted.
SEC. 4.Section 14132.969 of the Welfare and Institutions Code is amended to read:14132.969.(a)Subject to an annual appropriation for this express purpose, the department shall implement a medication therapy management (MTM) reimbursement methodology for covered pharmacist services related to the dispensing use of qualified specialty drugs by an eligible pharmacy contracted with the department pursuant to subdivision (c). drugs. MTM reimbursement pursuant to this section is intended to supplement ensure Medi-Cal payments are only made to eligible pharmacists or pharmacies for MTM pharmacist services provided in conjunction with certain specialty drug therapy categories, as identified by the department pursuant to paragraph (2) of subdivision (b).
(b)In implementing this section, the department shall do all of the following:
(1)Establish and maintain protocols and utilization controls for covered MTM pharmacist services.
(2)Establish and maintain a list of covered specialty drug therapy categories for which MTM pharmacist services reimbursement is available.
(3)Establish and maintain rates of reimbursement for covered MTM pharmacist services under contracts with participating pharmacies pursuant to subdivision (c).
(4)Establish and maintain the eligibility criteria and conditions for receipt of MTM pharmacist services reimbursement pursuant to this section.
(c)(1)MTM pharmacist services reimbursement pursuant to this section shall only be available to a Medi-Cal enrolled pharmacy or an eligible pharmacist that enters into an MTM pharmacist services contract with the department.
(2)For purposes of implementing this section, the department may enter into exclusive or nonexclusive contracts, or amend existing contracts, on a bid or negotiated basis. Contracts entered into or amended pursuant to this subdivision shall be exempt from Chapter 6 (commencing with Section 14825) of Part 5.5 of Division 3 of Title 2 of the Government Code, Part 2 (commencing with Section 10100) of Division 2 of the Public Contract Code, and the State Administrative Manual, and shall be exempt from the review or approval of any division of the Department of General Services.
(d)(1)This section shall apply to dates of service on or after July 1, 2021, or to dates of service on or after the effective date reflected in any necessary federal approvals obtained by the department pursuant to paragraph (2), whichever is later.
(2)The department shall seek any necessary federal approvals to implement this section.
(3)This section shall be implemented only to the extent that any necessary federal approvals are obtained and federal financial participation is available and is not otherwise jeopardized.
(e)This section neither restricts nor prohibits any does not restrict or prohibit services currently provided by pharmacists as authorized by law, including, but not limited to, this chapter, or including this chapter and the Medicaid state plan.
(f)Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section, in whole or in part, by means of provider bulletins or other similar instructions, without taking any further regulatory action.
(g)For purposes of this section, the following definitions apply:
(1)Medication therapy management or MTM means a distinct service or group of services, as determined by the department, that are provided by pharmacists to improve health outcomes of beneficiaries who are at risk of treatment failure due to noncompliance, nonadherence, or other factors found to negatively affect drug therapy outcomes.
(2)Specialty drugs has the same meaning as set forth in paragraph (13) of subdivision (a) of Section 14105.45.
SEC. 5.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
SECTION 1.It is the intent of the Legislature to enact subsequent legislation that establishes or clarifies the standard of care applicable to pharmacists in California.It is the intent of the Legislature to enact subsequent legislation that establishes or clarifies the standard of care applicable to pharmacists in California.
|
Date
|
Status
|
|---|---|
| Feb 2, 2026 | From committee: Filed with the Chief Clerk pursuant to Joint Rule 56. |
| Jan 31, 2026 | Died pursuant to Art. IV, Sec. 10(c) of the Constitution. |
| Jan 22, 2026 | In committee: Held under submission. |
| Jan 22, 2026 | In committee: Set, first hearing. Referred to suspense file. |
| Jan 13, 2026 | From committee: Do pass and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 15. Noes 0.) (January 13). Re-referred to Com. on APPR. |
| Jan 6, 2026 | Re-referred to Com. on HEALTH. |
| Jan 5, 2026 | From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended. |
| Apr 1, 2025 | Re-referred to Com. on HEALTH. |
| Mar 28, 2025 | From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended. |
| Mar 28, 2025 | Referred to Com. on HEALTH. |
| Feb 24, 2025 | Read first time. |
| Feb 22, 2025 | From printer. May be heard in committee March 24. |
| Feb 21, 2025 | Introduced. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Jan 13, 2026 | Do pass and be re-referred to the Committee on [Appropriations] with recommendation: To Consent Calendar | Assembly Standing Committee on Health |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
|
Organization
|
Position
|
Date
|
|---|---|---|
| California Society Of Health-System Pharmacists | ** Support | |
| City and County of San Francisco | ** Support | |
| North East Medical Services | ** Support |
Date of Hearing: January 22, 2026
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Buffy Wicks, Chair
ABPCA Bill Id:AB 1366
Author:(Flora) – As Amended Ver:January 5, 2026
Policy Committee: | Health | Vote: | 15 - 0 |
|
| ||
|
|
Urgency: No State Mandated Local Program: Yes Reimbursable: No
SUMMARY:
This bill requires the Medi-Cal program, a health care service plan (health plan), and a health insurer reimburse an advanced practice pharmacist (APP) for medication therapy management (MTM) services.
Specifically, this bill:
- Requires a health plan or health insurer pay or reimburse the cost of services performed by an APP if the APP is enrolled as a provider with the health plan or insurer.
- Requires the Medi-Cal program reimburse APPs for MTM services at the same fee schedule as for physician services.
- Requires the Department of Health Care Services (DHCS) seek federal approval of a state plan amendment to recognize pharmacists as health care providers at federally qualified health centers (FQHCs) for reimbursement under the Medi-Cal program.
- Requires DHCS implement an MTM reimbursement methodology for covered pharmacist services related to the use of qualified specialty drugs and to ensure Medi-Cal payments are made only to eligible APPs for MTM pharmacist services.
FISCAL EFFECT:
- Costs of an unknown amount to DHCS, potentially in the hundreds of thousands of dollars in the first year of implementation to: (a) create a billing pathway for APPs, (b) seek federal approval of a state plan amendment, and (c) develop and implement an MTM reimbursement methodology. Additional costs, potentially in the hundreds of thousands of dollars, ongoing, to reimburse APPs (federal funds, General Fund) in the Medi-Cal program.
- Minor and absorbable costs to the Department of Managed Health Care and the Department of Insurance.
COMMENTS:
- Purpose. This bill is sponsored by the California Society of Health-System Pharmacists. According to the author:
[MTM] is a proven, cost-effective service that improves patient outcomes, reduces healthcare spending, and addresses chronic disease management gaps—particularly in underserved communities. Pharmacists are uniquely qualified medication experts who help patients manage complex drug regimens, identify harmful interactions, and increase adherence to prescribed treatments. These services, whether provided in a community pharmacy, clinic, hospital, or via telehealth, directly reduce emergency room visits, hospitalizations, and avoidable complications. Limiting reimbursement to services performed within a brick-and-mortar pharmacy ignores the evolving realities of healthcare delivery, especially in the face of widespread pharmacy closures and the expansion of mobile and remote care models. Paying pharmacists for MTM regardless of location not only aligns with modern healthcare infrastructure, but also ensures equitable access to life-saving services.
- Background. MTM and Pharmacy Closures. MTM services can reduce adverse drug events, improve medication adherence and health outcomes, prevent hospitalizations, and reduce costs. Under existing law, health plans and insurers may reimburse pharmacists for MTM services provided within or affiliated with a pharmacy. However, individual pharmacists, such as those employed in hospitals, FQHCs and other clinics, academic medical centers, and physician practices, are not permitted to bill for these services unless affiliated with a pharmacy. Research indicates one in three pharmacies in the U.S. have closed since 2010, creating pharmacy deserts that limit patient access to prescriptions, as well as pharmacist-provided services such as MTM. Pharmacy closures are expected to continue.
APPs. Existing law authorizes pharmacists to furnish compounded drug products, transmit a valid prescription to another pharmacist, and administer drugs and biologicals pursuant to a prescriber's order. SB 493 (Hernandez), Chapter 469, Statutes of 2013, authorized pharmacists to furnish self-administered hormonal contraceptives, vaccines, nicotine replacement products, and travel medications. SB 493 also authorized the State Board of Pharmacy to recognize APPs who may perform patient assessments, order and interpret drug therapy-related tests, refer patients to other health care providers, participate in the evaluation and management of diseases and health conditions in collaboration with other health care providers, and initiate, adjust, or discontinue drug therapy.
Medi-Cal. Medi-Cal covers pharmacist services in contracting pharmacies. According to the Assembly Health Committee analysis of this bill, to reimburse pharmacists directly, DHCS would likely need to create a pathway whereby pharmacists could enroll as billing providers.
Analysis Prepared by: Allegra Kim / APPR. / (916) 319-2081
Date of Hearing: January 13, 2026
ASSEMBLY COMMITTEE ON HEALTH
Mia Bonta, Chair
ABPCA Bill Id:AB 1366
Author:(Flora) – As Amended Ver:January 5, 2026
SUBJECT: Reimbursement for pharmacist services.
SUMMARY: Requires advanced practice pharmacists (APPs) enrolled as providers with a health care service plan (health plan), health insurer, or the Medi-Cal program to be reimbursed for medication therapy management (MTM) services. Specifically, this bill:
- Requires a health plan or health insurer to pay or reimburse the cost of services performed by an APP if the APP is enrolled as a provider with the plan or insurer.
- Requires the Medi-Cal program to reimburse APP services, including MTM services, at the same fee schedule for physician services.
- Requires the Department of Health Care Services (DHCS) to implement an MTM reimbursement methodology to ensure that Medi-Cal payments are made to eligible APPs, in addition to pharmacies, for MTM pharmacist services.
- Requires DHCS to seek federal approval of a state plan amendment to recognize pharmacists as health care providers at federally qualified health centers (FQHCs) for reimbursement purposes under the Medi-Cal program.
EXISTING LAW:
- Establishes the Department Managed Health Care (DMHC) to regulate health plans under the Knox-Keene Health Care Service Plan Act of 1975 and California Department of Insurance (CDI) to regulate health insurers. [Health and Safety Code (HSC) § 1340, et seq. and Insurance Code (INS) § 106, et seq.]
- Requires a health plan or insurer, that offers coverage for a service that is within the scope of practice of a duly licensed pharmacist to pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy or a pharmacist at an out-of-network pharmacy if the health care service plan has an out-of-network pharmacy benefit. Authorizes payment or reimbursement for a service performed by a duly licensed pharmacist only when all of the following conditions are met:
- The service performed is within the lawful scope of practice of the pharmacist; and,
- The coverage otherwise provides reimbursement for identical services performed by other licensed health care providers. [HSC §1368.5 and INS §10125.1]
- Establishes the Medi-Cal Program, administered by DHCS, to provide comprehensive health benefits to low-income individuals who meet specified eligibility criteria. [Welfare and Institutions Code (WIC) § 14000 et seq.]
- Establishes pharmacist services as a benefit under the Medi-Cal program, subject to federal approval. Sets a rate of reimbursement for pharmacist services as 85% of the fee schedule for physician services under the Medi-Cal program. [WIC § 14132.968]
- Requires DHCS to implement an MTM reimbursement methodology for covered pharmacist services related to the dispensing of qualified specialty drugs by an eligible contracting pharmacy. Permits MTM reimbursement only to eligible pharmacies for MTM services. [WIC § 14132.969]
- Defines, for purposes of reimbursement to an FQHC or Rural Health Center (RHC), an FQHC or RHC “visit” as a face-to-face encounter between an FQHC or RHC patient and a physician, physician assistant, nurse practitioner, certified nurse-midwife, clinical psychologist, licensed clinical social worker, licensed professional clinical counselor, or a visiting nurse. A visit also includes a face-to-face encounter between an FQHC or RHC patient and a comprehensive perinatal practitioner providing comprehensive perinatal services, a four-hour day of attendance at an adult day health care center, and any other provider identified in the state plan’s definition of an FQHC or RHC visit. [WIC § 14132.100]
- Establishes licensure for an APP and requires the person to meet all of the following:
- Hold an active license to practice pharmacy that is in good standing; and,
- Satisfy any two of the following criteria:
- Earn certification in a relevant area of practice, including, but not limited to, ambulatory care, critical care, geriatric pharmacy, nuclear pharmacy, nutrition support pharmacy, oncology pharmacy, pediatric pharmacy, pharmacotherapy, or psychiatric pharmacy, from an organization recognized by the Accreditation Council for Pharmacy Education or another entity recognized by Board of Pharmacy (BOP);
- Complete a postgraduate residency through an accredited postgraduate institution where at least 50% of the experience includes the provision of direct patient care services with interdisciplinary teams; or,
- Have provided clinical services to patients for at least one year under a collaborative practice agreement or protocol with a physician, APP, pharmacist practicing collaborative drug therapy management, or health system. [Business and Professions Code (BPC) § 4210]
- Allows a pharmacist recognized by the BOP as an APP to do all of the following:
- Perform patient assessments;
- Order and interpret drug therapy-related tests;
- Refer patients to other health care providers;
- Participate in the evaluation and management of diseases and health conditions in collaboration with other health care providers; and,
- Initiate, adjust, or discontinue drug therapy, as specified. [BPC § 4052.6]
FISCAL EFFECT: Unknown. This bill has not yet been analyzed by a fiscal committee.
COMMENTS:
- PURPOSE OF THIS BILL. According to the author, MTM is a proven, cost-effective service that improves patient outcomes, reduces healthcare spending, and addresses chronic disease management gaps—particularly in underserved communities. The author states that pharmacists are uniquely qualified medication experts who help patients manage complex drug regimens, identify harmful interactions, and increase adherence to prescribed treatments. The author continues that these services, whether provided in a community pharmacy, clinic, hospital, or via telehealth, directly reduce emergency room visits, hospitalizations, and avoidable complications. The author argues that limiting reimbursement to services performed within a brick-and-mortar pharmacy ignores the evolving realities of healthcare delivery, especially in the face of widespread pharmacy closures and the expansion of mobile and remote care models. The author concludes that paying pharmacists for MTM regardless of location not only aligns with modern healthcare infrastructure but also ensures equitable access to life-saving services for the Medi-Cal patients who need them most.
- BACKGROUND.
- MTM. MTM is a strategy to improve health outcomes and detect and prevent costly medication problems. MTM services aim to improve medication adherence, reduce adverse drug events, prevent hospitalizations, and produce measurable cost savings. Numerous studies provided by the author’s office offer evidence that MTM programs can reduce total healthcare spending by optimizing therapeutic outcomes, eliminating unnecessary or duplicative medication use, and improving management of chronic conditions such as diabetes, hypertension, and asthma. Current law authorizes pharmacists to be reimbursed for MTM services; however, those services must be provided within or affiliated with a pharmacy. Individual pharmacists, such as those employed in hospitals, FQHCs, rural health clinics, mobile clinics, academic medical centers, and physician practices, are not permitted to bill for these services without affiliation at a pharmacy. This discrepancy in reimbursement structure is impactful as brick-and-mortar pharmacies are rapidly declining across the state. According to research published by the UC Berkeley School of Public Health and the University of Southern California, 1 in 3 pharmacies have closed since 2010 and thousands more closures are expected in the coming years. These closures have created pharmacy deserts that not only impact patient access to prescriptions, but also pharmacist-provided services such as MTM due to reimbursement limitations.
- APPs. Existing law authorizes pharmacists to furnish compounded drug products, transmit a valid prescription to another pharmacist, and administer drugs and biologicals pursuant to a prescriber's order. SB 493 (Hernandez), Chapter 469, Statutes of 2013, expands the scope of pharmacists to authorize them to furnish self-administered hormonal contraceptives, vaccines, nicotine replacement products, and travel medications. Additionally, SB 493 authorizes the BOP to recognize APPs who can perform patient assessments, order and interpret drug therapy-related tests, refer patients to other health care providers, participate in the evaluation and management of diseases and health conditions in collaboration with other health care providers, and initiate, adjust, or discontinue drug therapy.
- Reimbursement to Pharmacists Would be New for Medi-Cal. Medi-Cal covers pharmacist services; however, these services are reimbursed to contracting pharmacies, not directly to pharmacists. For pharmacists to receive reimbursement directly, DHCS would likely have to create an enrollment pathway, and pharmacists would have to newly enroll as billing providers. Pharmacists are also similarly not recognized as “reimbursable” providers within an FQHC or RHC if services are provided outside of a pharmacy [see 6) above of Existing Law for the list of recognized providers within an FQHC or RHC setting]. Enrolling and reimbursing advance practice pharmacists directly could improve access to services provided by these pharmacists, such as MTM, and could increase the flexibility of how pharmacists may be used as part of care teams within health care systems.
- SUPPORT. The California Society of Health-System Pharmacists (CSHP), sponsors of this bill, state that under current law, pharmacists’ MTM services can generally be reimbursed only when delivered within or affiliated with a brick-and-mortar pharmacy, despite the fact that pharmacists increasingly practice in clinics, hospitals, physician group practices, mobile health units, and other community-based settings. CSHP continues that this outdated restriction fails to reflect modern, team-based care models and has become especially harmful as pharmacy closures accelerate in low-income and rural communities, eliminating primary access points for many Medi-Cal beneficiaries. CSHP argues that this bill addresses this gap by allowing Medi-Cal and health plans to reimburse individual pharmacists enrolled as providers for MTM services regardless of whether those services are delivered in a traditional pharmacy or in another clinical setting. CSHP concludes that by recognizing pharmacists as reimbursable providers in a wider range of settings, this bill will expand access to preventive and chronic care services, improve continuity of care, and advance health equity for patients living in “pharmacy deserts” and other medically underserved communities.
- PREVIOUS LEGISLATION.
- AB 317 (Weber), Chapter 322, Statutes of 2023, requires, instead of permits, a health plan and specified disability insurers that offer coverage for a service that is within the scope of practice of a duly licensed pharmacist to pay or reimburse the cost of services performed by a pharmacist at an in-network pharmacy or by a pharmacist at an out-of-network pharmacy if the health plan or insurer has an out-of-network pharmacy benefit.
- AB 1114 (Eggman), Chapter 602, Statutes of 2016, adds to the schedule of Medi-Cal benefits pharmacist services, as specified, subject to DHCS protocols and utilization controls. Requires the rate of reimbursement for pharmacist services to be at 85% of the fee schedule for physician services under the Medi-Cal program and requires DHCS to establish a fee schedule. Authorizes DHCS to implement these provisions by means of all-county letters, plan letters, plan or provider bulletins, or similar instructions, without taking regulatory action, until regulations are adopted, and requires DHCS to adopt those regulations by July 1, 2021. Requires these provisions to be implemented only to the extent that federal financial participation is available and the necessary federal approvals are obtained.
- SB 493 (Hernandez), Chapter 469, Statutes of 2013, authorizes a pharmacist to administer drugs and biological products that have been ordered by a prescriber. Authorizes pharmacists to perform other functions, including, among other things, to furnish self-administered hormonal contraceptives, nicotine replacement products, and prescription medications not requiring a diagnosis that are recommended for international travelers, as specified. Authorizes pharmacists to order and interpret tests for the purpose of monitoring and managing the efficacy and toxicity of drug therapies, and to independently initiate and administer routine vaccinations, as specified. Establishes BOP recognition for an APP, as defined, and specifies the criteria for that recognition, and specifies additional functions that may be performed by an APP, including, among other things, performing patient assessments, and certain other functions, as specified. Authorizes BOP, by regulation, to set the fee for the issuance and renewal of APP recognition at the reasonable cost of regulating APPs pursuant to these provisions, not to exceed $300.
REGISTERED SUPPORT / OPPOSITION:
Support
California Society of Health-System Pharmacists (Sponsor)
City and County of San Francisco
North East Medical Services
Opposition
None on file
Analysis Prepared by: Riana King / HEALTH / (916) 319-2097
Bill Author
Bill Co-Author(s):